Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastomaYoshinari Shinsato, Kazunori Arita|Oncotarget|2013Cited by 78
High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiformeMuhammad Kamil, Kazunori Arita|British Journal of Cancer|2019Cited by 46
Anaplastic astrocytoma cells not detectable on autopsy following long-term temozolomide treatment: A case reportHirofumi Hirano, Kazunori Arita|Molecular and Clinical Oncology|2017Cited by 4